Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul/Aug;135(4):483-491.
doi: 10.1177/0033354920925094. Epub 2020 Jun 9.

Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States

Nicole L Johnson  1 , Katharine J Head  1 , Susanna Foxworthy Scott  2 , Gregory D Zimet  3
Affiliations

Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States

Nicole L Johnson et al. Public Health Rep. 2020 Jul/Aug.

Abstract

Objectives: Cervical cancer is the second-most common type of cancer among women aged 15-44, and racial, ethnic, and economic disparities exist in survival rates despite widely available screening tests and early treatment options. The objective of this study was to describe the association among knowledge, sociodemographic characteristics, and cervical cancer screening, with the goal of developing interventions to prevent cervical cancer in populations at risk of the disease.

Methods: In 2017, we conducted a nationwide survey of women in the United States aged ≥18 who had ever received a Papanicolaou (Pap) test (N = 630). We conducted t tests and one-way analysis of variance to determine sociodemographic differences (age, education, race, ethnicity, income, type of health insurance) in knowledge about cervical cancer screening (Pap test and human papillomavirus [HPV] test). We used logistic regressions to define significant determinants of cervical cancer screening behaviors in the previous 5 years.

Results: Of 629 respondents, 407 (64.7%) had an annual household income <$30 000, and 322 of 536 (60.1%) respondents had government-provided health insurance. Of 630 women who had ever had a Pap test, 425 (67.5%) had an HPV test. Hispanic and non-Hispanic white women were more likely than Hispanic and non-Hispanic black women (odds ratio [OR] = 2.49; 95% CI, 1.12-4.54; P = .02) and women with government-provided health insurance (OR = 1.91; 95% CI, 1.08-3.37; P = .03) were more likely than women with private health insurance to have received a Pap test in the previous 5 years. Knowledge of HPV was a significant predictor of having received an HPV test in the previous 5 years (OR = 1.37; 95% CI, 1.22-1.54; P < .001).

Conclusion: Disparities in cervical cancer screening among sociodemographic groups of women suggest the need for targeted interventions to improve knowledge about Pap and HPV tests.

Keywords: HPV knowledge; Pap test knowledge; cervical cancer screening; high-risk populations; human papillomavirus (HPV).

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Howlader N., Noone AM., Krapcho M. et al. SEER Cancer Statistics Review (CSR), 1975-2016. National Cancer Institute; 2019. Based on November 2018 SEER data submission posted to the SEER website. Accessed March 10, 2020 https://seer.cancer.gov/csr/1975_2016
    1. American College of Obstetricians and Gynecologists Practice advisory: cervical cancer screening (update). Accessed March 18, 2020 https://www.acog.org/clinical/clinical-guidance/practice-advisory/articl...
    1. US Preventive Services Task Force Final update summary: cervical cancer: screening. August 29, 2018. Accessed January 29, 2019 https://www.uspreventiveservicestaskforce.org/Page/Document/Recommendati...
    1. Huh WK., Ault KA., Chelmow D. et al.. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstet Gynecol. 2015;125(2):330-337. 10.1097/AOG.0000000000000669 - DOI - PubMed
    1. Bynum SA., Wright MS., Brandt HM., Burgis JT., Bacon JL. Knowledge, beliefs, and attitudes related to human papillomavirus infection and vaccination, Pap tests, and cervical intraepithelial neoplasia among adolescent girls and young women. J S C Med Assoc. 2009;105(7):267-272. - PubMed

MeSH terms